ARVINAS, INC. Basic Shares Outstanding (Weighted Average)
ARVINAS, INC. (ARVN) reported Basic Shares Outstanding (Weighted Average) of 64.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- ARVINAS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 64.80M shares, a 11.23% decline year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 64.00M shares, a 11.72% decline year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 64.90M shares, a 9.74% decline year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 73.20M shares, a 1.53% increase year-over-year.
- ARVINAS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 70.90M shares, a 1.39% decline from fiscal 2024.
- ARVINAS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 71.90M shares, a 29.55% increase from fiscal 2023.
- ARVINAS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 55.50M shares, a 4.32% increase from fiscal 2022.
- ARVINAS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 53.20M shares, a 6.40% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 64.80M shares 10-Q · filed 2026-08-04 | 64.40M shares 10-Q · filed 2026-08-04 | 64.57M shares derived: average of 3 quarters · filed 2026-08-04 | 66.72M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 64.00M shares 10-Q · filed 2026-05-11 | 64.45M shares derived: average of 2 quarters · filed 2026-05-11 | 67.37M shares derived: average of 3 quarters · filed 2026-05-11 | 68.78M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 64.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 69.05M shares derived: average of 2 quarters · filed 2026-02-24 | 70.37M shares derived: average of 3 quarters · filed 2026-08-04 | 70.90M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 73.20M shares 10-Q · filed 2025-11-05 | 73.10M shares derived: average of 2 quarters · filed 2026-08-04 | 72.90M shares 10-Q · filed 2025-11-05 | 72.65M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 73.00M shares 10-Q · filed 2026-08-04 | 72.80M shares 10-Q · filed 2026-08-04 | 72.47M shares derived: average of 3 quarters · filed 2026-08-04 | 72.38M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 72.50M shares 10-Q · filed 2026-05-11 | 72.20M shares derived: average of 2 quarters · filed 2026-05-11 | 72.17M shares derived: average of 3 quarters · filed 2026-05-11 | 72.10M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 71.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 72.00M shares derived: average of 2 quarters · filed 2026-02-24 | 71.97M shares derived: average of 3 quarters · filed 2026-02-24 | 71.90M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 72.10M shares 10-Q · filed 2025-11-05 | 72.00M shares derived: average of 2 quarters · filed 2025-11-05 | 71.90M shares 10-Q · filed 2025-11-05 | 69.22M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 71.90M shares 10-Q · filed 2025-08-06 | 71.70M shares 10-Q · filed 2025-08-06 | 68.27M shares derived: average of 3 quarters · filed 2026-02-24 | 64.72M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 71.70M shares 10-Q · filed 2025-05-01 | 66.45M shares derived: average of 2 quarters · filed 2026-02-24 | 62.33M shares derived: average of 3 quarters · filed 2026-02-24 | 60.10M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 61.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 57.65M shares derived: average of 2 quarters · filed 2026-02-24 | 56.23M shares derived: average of 3 quarters · filed 2026-02-24 | 55.50M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 54.10M shares 10-Q · filed 2024-10-30 | 53.75M shares derived: average of 2 quarters · filed 2024-10-30 | 53.60M shares 10-Q · filed 2024-10-30 | 53.58M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | 53.40M shares 10-Q · filed 2024-07-30 | 53.40M shares 10-Q · filed 2024-07-30 | 53.40M shares derived: average of 3 quarters · filed 2025-02-11 | 53.35M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | 53.30M shares 10-Q · filed 2024-05-07 | 53.40M shares derived: average of 2 quarters · filed 2025-02-11 | 53.33M shares derived: average of 3 quarters · filed 2025-02-11 | 53.30M shares derived: average of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | 53.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | 53.35M shares derived: average of 2 quarters · filed 2025-02-11 | 53.30M shares derived: average of 3 quarters · filed 2025-02-11 | 53.20M shares 10-K · filed 2025-02-11 |
| 2022-09-30 | 53.20M shares 10-Q · filed 2023-11-07 | 53.20M shares derived: average of 2 quarters · filed 2023-11-07 | 53.10M shares 10-Q · filed 2023-11-07 | 53.02M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 53.20M shares 10-Q · filed 2023-08-08 | 53.10M shares 10-Q · filed 2023-08-08 | 52.97M shares derived: average of 3 quarters · filed 2024-02-27 | 52.17M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 53.00M shares 10-Q · filed 2023-05-05 | 52.85M shares derived: average of 2 quarters · filed 2024-02-27 | 51.83M shares derived: average of 3 quarters · filed 2024-02-27 | 51.10M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 52.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 51.25M shares derived: average of 2 quarters · filed 2024-02-27 | 50.47M shares derived: average of 3 quarters · filed 2024-02-27 | 50.00M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 49.80M shares 10-Q · filed 2022-11-09 | 49.35M shares derived: average of 2 quarters · filed 2022-11-09 | 49.10M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 48.90M shares 10-Q · filed 2022-08-04 | 48.70M shares 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 48.60M shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 39.50M shares 10-K · filed 2023-02-23 | |||
| 2019-12-31 | 32.90M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |